推薦產品
等級
pharmaceutical primary standard
API 家族
vinorelbine
製造商/商標名
EDQM
應用
pharmaceutical (small molecule)
格式
neat
儲存溫度
−70°C
InChI
1S/C45H54N4O8.2C4H6O6/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7;2*5-1(3(7)8)2(6)4(9)10/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3;2*1-2,5-6H,(H,7,8)(H,9,10)/t28?,37-,38+,39+,42+,43+,44-,45-;2*1-,2-/m011/s1
InChI 密鑰
CILBMBUYJCWATM-NPJYPKOYSA-N
尋找類似的產品? 前往 產品比較指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Vinorelbine tartrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
包裝
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他說明
Sales restrictions may apply.
訊號詞
Danger
危險分類
Acute Tox. 2 Oral - Carc. 2 - Muta. 2 - Repr. 1B - STOT RE 1
儲存類別代碼
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Development and Validation of New RPHPLC Method for the Estimation of Vinorelbine in Pharmaceutical Dosage Forms.
International Journal of Research in Pharmacy and Chemistry, 201(3), 3-3 (2013)
Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
Internal medicine (Tokyo, Japan), 40(8), 779-782 (2001)
Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
Fundamental & Clinical Pharmacology, 19(5), 545-553 (2005)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務